Position history for BNP PARIBAS FINANCIAL MARKETS's holdings in DENALI THERAPEUTICS INC
BNP PARIBAS FINANCIAL MARKETS holds 15,497 shares of DNLI (DENALI THERAPEUTICS INC), worth $255,855 as of 2025-Q4. The position was decreased (-94.1% shares). DNLI represents 0.0% of BNP PARIBAS FINANCIAL MARKETS's portfolio.
Current Value
$255,855
Current Shares
15,497
Total Value Change
+$61,596
Total Shares Change
+7,131
Other major holders of DNLI: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Decreased |
| 15,497 |
-94.1% |
| $255,855 |
| 0.0% |
| $16.41 |
0 |
| 2025-Q3 | Increased | 264,061 | +1283.8% | $3.8M | 0.0% | $14.52 | 43 |
| 2025-Q2 | Increased | 19,082 | +119.0% | $266,957 | 0.0% | $14.10 | 37 |
| 2025-Q1 | Decreased | 8,715 | -45.3% | $118,480 | 0.0% | $14.78 | 0 |
| 2024-Q4 | Decreased | 15,943 | -42.3% | $324,918 | 0.0% | $20.24 | 0 |
| 2024-Q3 | Increased | 27,625 | +230.2% | $804,716 | 0.0% | $29.43 | 40 |
| 2024-Q2 | Decreased | 8,366 | -88.4% | $194,259 | 0.0% | $23.22 | 0 |